<DOC>
	<DOCNO>NCT02352454</DOCNO>
	<brief_summary>The aim trial demonstrate effectiveness complete wound heal prospective , open-label , randomized trial venous leg ulcer ( VLU ) n treat use Aurix compare patient receive undefined Usual Customary Care ( UCC )</brief_summary>
	<brief_title>Effectiveness Aurix Therapy Venous Leg Ulcers</brief_title>
	<detailed_description>Recurrence ulcer leg common ; two-thirds patient likely experience recur ulcer first ulcer . While treatment underlie venous disease , depend mode treatment , low recurrence rate many patient , affect recurrence . Aurix platelet-rich plasma ( PRP ) gel use treatment non-healing chronic wound . The aim trial demonstrate effectiveness , measure complete wound healing , prospective , randomized trial venous leg ulcer treat use Aurix standard care compare 1:1 patient receive undefined Usual Customary Care ( UCC ) .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>1 . Medicare eligible 2 . ≥18 year age 3 . Proven venous disease 4 . The large nonhealing wound , multiple wound present , single wound treat ( Index Ulcer ) locate include knee ankle 5 . For subject potentially multiple eligible VLUs , large ulcer select Index Ulcer study . There must least 4 cm Index Ulcer ulcer ; ulcer closer 4 cm , subject enrol ( screen failure ) 6 . Debrided ulcer size 2 cm2 200 cm2 7 . Subject receive UCC care ≥ 2 week treat wound clinic 8 . Demonstrated adequate compression regimen 9 . Duration ≥ 1 month first visit 10 . Subject must willing comply Protocol , assess enrol clinician 1 . Subjects know sensitive Aurix component ( calcium chloride , thrombin , ascorbic acid ) and/or material bovine origin 2 . Presence another wound concurrently treat might interfere treatment index wind Aurix 3 . Ulcer VLU pathophysiology ( e.g. , pure diabetic , vasculitic , radiation , rheumatoid , collagen vascular disease , pressure , arterial etiology ) 4 . Patients chemotherapeutic agent malignancy wind area 5 . Subjects cognitively impair 6 . Serum albumin less 2.5 g/dL 7 . Plasma Platelet count le 100 x 109/L 8 . Hemoglobin le 10.5 g/dL 9 . Subject inadequate venous access repeat blood draw require Aurix Administration .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Non Healing Wound</keyword>
</DOC>